Mplx (NYSE:MPLX) Announces Earnings Results, Beats Expectations By $0.02 EPS
Gartner officials raised the adjusted earnings per share projection to at least $14.65 following stronger-than-anticipated quarterly performance and improved adjusted operating metrics.
- On Tuesday, November 3, 2026, Fortis Inc. released third-quarter results and introduced a new $32.2 billion five-year capital plan while increasing its fourth-quarter dividend by 4%.
- The company reported third-quarter net earnings of $474 million, or $0.92 per common share, up from $409 million, or $0.81 per share, in the same quarter of 2025.
- Fortis' new $32.2 billion capital plan, $3.4 billion higher than the previous forecast, emphasizes transmission investments at ITC and expanded liquefied natural gas storage at FortisBC Energy.
- ITC won a competitive $1.0 billion Iowa transmission project, with $0.5 billion included in the five-year plan; an Arizona Corporation Commission Administrative Law Judge issued a recommended rate order for Tucson Electric Power .
- Fortis extended annual dividend growth guidance of 4-6% through 2031, supported by regulated investment opportunities and long-term rate base expansion projected to reach $63.9 billion by 2031.
25 Articles
25 Articles
Mplx (NYSE:MPLX) Announces Earnings Results, Beats Expectations By $0.02 EPS
Mplx (NYSE:MPLX - Get Free Report) issued its quarterly earnings results on Tuesday. The pipeline company reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.13 by $0.02. The business had revenue of $3.27 billion during the quarter, compared to analyst estimates of $3.35 billion. Mplx had a net margin of 35.75% and a return on equity of 32.83%.
Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
Key PointsPfizer's numbers were strong in its most recent quarter, with both its top and bottom lines coming in better than analyst forecasts.The company experienced 32% growth from launched and acquired products, highlighting its underrated growth potential.Its valuation remains modest, despite the stock's strong gains this year.Motley Fool Issues Rare "Total Conviction" Buy Alert › On Tuesday, healthcare giant Pfizer (NYSE:PFE) reported its th…
Pfizer Raises 2026 Revenue Forecast to 62-64 Billion
Pfizer beat third-quarter analyst estimates and raised its 2026 revenue and adjusted-earnings forecasts, as growth in several medicines largely offset falling COVID-product and Prevnar sales; investors are also watching cost cuts, upcoming drug exclusivity losses and its obesity pipeline. Its Indian subsidiary reported a sharp quarterly profit increase, driven partly by an exceptional gain from the sale of Minipress XL. · 21 sources across the spectrum on IJR News.
Coverage Details
Bias Distribution
- 47% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
